insights_auto
Why is CHGCF down 2,84%?
Dive Deeperchevron_right
CHGCF:OTCMKTS
Chugai Pharmaceutical Co Ltd
37,18 US$
arrow_downward
-2,84%(-1,08) 1D
8 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCF...
Open
38,14 US$
High
39,35 US$
Low
36,52 US$
Mkt. cap
10,11 ტრლ.
Avg. vol.
10,95 ათ.
Volume
11,06 ათ.
52-wk high
68,08 US$
52-wk low
34,79 US$
Beta
1,91
Shares outstanding
1,68 მლრდ.
No. of employees
5 ათ.
Open
38,14 US$
High
39,35 US$
Low
36,52 US$
Mkt. cap
10,11 ტრლ.
Avg. vol.
10,95 ათ.
Volume
11,06 ათ.
52-wk high
68,08 US$
52-wk low
34,79 US$
Beta
1,91
Shares outstanding
1,68 მლრდ.
No. of employees
5 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
13 საათის წინ
Chugai Pharmaceutical stock loses 0.72 percent after-hours to EUR 34.36
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOოსამუ ოკუდა
Employees5,1 ათ.
Founded10 მარ. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp